Targeting tumor vulnerabilities associated with loss of heterozygosity

We show that N-acetyltransferase 2 (NAT2) loss of heterozygosity can be targeted in >4% of colorectal cancers with the use of a small molecule. We identify and describe the effect of a compound that impairs the growth of colorectal tumors with slow NAT2 activity by half when compared to wild-type...

Full description

Bibliographic Details
Main Authors: Veronica Rendo, Ivaylo Stoimenov, Tobias Sjöblom
Format: Article
Language:English
Published: Taylor & Francis Group 2020-07-01
Series:Molecular & Cellular Oncology
Subjects:
Online Access:http://dx.doi.org/10.1080/23723556.2020.1759390